|
|
Volumn 52, Issue 2, 2001, Pages 265-273
|
|
Cardiac remodeling after long term norepinephrine treatment in rats
|
|
Author keywords
Adrenergic (ant)agonists; Extracellular matrix; Fibrosis; Gene expression; Hemodynamics; Hypertrophy; Receptors
|
|
Indexed keywords
COLLAGEN TYPE 1;
COLLAGEN TYPE 3;
GELATINASE A;
HEAT SHOCK PROTEIN 47;
MESSENGER RNA;
NORADRENALIN;
PROTEIN;
SCLEROPROTEIN;
TISSUE INHIBITOR OF METALLOPROTEINASE 2;
UNCLASSIFIED DRUG;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ARTICLE;
COLLAGEN DEGRADATION;
COLLAGEN SYNTHESIS;
CONTROLLED STUDY;
DOSE TIME EFFECT RELATION;
DRUG EFFECT;
ENZYME ACTIVITY;
EXTRACELLULAR MATRIX;
FEMALE;
HEART FUNCTION;
HEART LEFT VENTRICLE;
HEART MUSCLE CELL;
HEART MUSCLE FIBROSIS;
HEART VENTRICLE HYPERTROPHY;
HEART VENTRICLE REMODELING;
HEART WEIGHT;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN METABOLISM;
RAT;
ADRENERGIC ANTAGONISTS;
ANALYSIS OF VARIANCE;
ANIMALS;
BLOTTING, WESTERN;
CALCIUM CHANNEL BLOCKERS;
CARBAZOLES;
COLLAGEN TYPE I;
COLLAGEN TYPE III;
ELECTROPHORESIS, POLYACRYLAMIDE GEL;
EXTRACELLULAR MATRIX;
FEMALE;
FIBROSIS;
GENE EXPRESSION;
HYPERTROPHY, LEFT VENTRICULAR;
INFUSIONS, INTRAVENOUS;
MATRIX METALLOPROTEINASE 2;
MYOCARDIUM;
NISOLDIPINE;
NOREPINEPHRINE;
PROPANOLAMINES;
RATS;
RATS, SPRAGUE-DAWLEY;
RNA, MESSENGER;
TIME FACTORS;
TISSUE INHIBITOR OF METALLOPROTEINASE-2;
VENTRICULAR REMODELING;
|
|
EID: 0034782715
PISSN: 00086363
EISSN: None
Source Type: Journal
DOI: 10.1016/S0008-6363(01)00398-4 Document Type: Article |
|
Times cited : (98)
|
|
References (28)
|
